Valuation: CJ Bioscience, Inc.

Market Cap 43.51B 32.43M 29.54M 27.22M 24.76M 46.45M 3B 48.82M 331M 132M 1.64B 122M 119M 5.15B P/E 2024
-2.85x
P/E 2025 -5.07x
Enterprise Value 3.08B 2.3M 2.09M 1.93M 1.75M 3.29M 213M 3.46M 23.46M 9.32M 116M 8.62M 8.43M 365M EV / Sales 2024
19x
EV / Sales 2025 22x
Free-Float
38.05%
Yield 2024 *
-
Yield 2025 -
1 day-1.91%
1 week-6.20%
Current month-9.88%
1 month-10.48%
3 months-13.51%
6 months-45.05%
Current year-64.27%
1 week 3,200
Extreme 3200.00000000
3,630
1 month 3,200
Extreme 3200.00000000
3,980
Current year 3,060
Extreme 3060
9,420
1 year 3,060
Extreme 3060
10,200
3 years 3,060
Extreme 3060
18,800
5 years 3,060
Extreme 3060
55,100
10 years 3,060
Extreme 3060
73,000
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 55 -
Director TitleAgeSince
Director/Board Member 54 -
Director/Board Member 69 -
Director/Board Member 58 -
Change 5-day change 1-year change 3-year change Capi.($)
-1.91%-6.20%-62.16%-78.40% 33.26M
-2.49%-3.76%+50.31%+62.10% 65.42B
-0.63%-2.91%+6.20%+89.22% 58.91B
-2.37%-2.22%+22.87%+82.31% 55.24B
-2.19%-6.15%+11.92%+108.08% 45.66B
-1.89%-7.28%+13.22%+19.74% 41.29B
-0.93%-0.47%+19.73%+43.75% 36.82B
+1.11%-6.44%+130.68%+641.83% 34.48B
-0.80%+0.61%+77.26%+56.26% 32.5B
-2.17%+16.65%-29.21%+474.05% 31.69B
Average -1.43%-1.62%+24.08%+149.89% 40B
Weighted average by Cap. -1.49%-1.64%+31.90%+149.75%

Financials

2024 2025
Net sales 3.47B 2.58M 2.35M 2.17M 1.97M 3.7M 239M 3.89M 26.39M 10.49M 131M 9.7M 9.49M 410M 3.69B 2.75M 2.51M 2.31M 2.1M 3.94M 255M 4.14M 28.11M 11.17M 139M 10.33M 10.11M 437M
Net income -32.84B -24.48M -22.29M -20.54M -18.69M -35.06M -2.27B -36.84M -250M -99.37M -1.24B -91.84M -89.9M -3.89B -24B -17.89M -16.3M -15.02M -13.66M -25.63M -1.66B -26.93M -183M -72.64M -905M -67.14M -65.72M -2.84B
Net Debt -65.96B -49.17M -44.78M -41.26M -37.53M -70.41M -4.55B -74M -502M -200M -2.49B -184M -181M -7.8B -40.43B -30.13M -27.45M -25.29M -23.01M -43.16M -2.79B -45.36M -308M -122M -1.52B -113M -111M -4.78B
Projected Income Statement - Annual - CJ Bioscience, Inc.
Logo CJ Bioscience, Inc.
CJ Bioscience Inc, formerly ChunLab Inc, is a Korea-based company principally engaged in the provision of microbial bioinformatics platform and solutions. The Company mainly provides microbial bioinformatics analysis services and microbiome-based healthcare services through bioinformatics database and cloud analytics platform. The Company also develops microbiome therapies and infection diagnosis solutions.
Employees
81
Date Price Change Volume
20/11/26 ₩3,330.00 -1.91% 1,082
19/11/26 ₩3,395.00 -0.15% 4,325
18/11/26 ₩3,400.00 -2.72% 5,036
17/11/26 ₩3,495.00 -1.41% 2,111
16/11/26 ₩3,545.00 -0.14% 2,807
  1. Stock Market
  2. Stocks
  3. A311690 Stock